We analyzed a variety of clinical factors (gender, age, β2-MG, type of light chain, ISS stage, plasma cell number in bone marrow, peak concentration of IL-6 and CRP, and minimum value of CD4/CD8) that may be associated with CRS in patients with multiple myeloma separately. This evidence concerns the gene CD8A and AL amyloidosis.